AC
ACIU icon

Athanor Capital’s AC Immune ACIU Stock Holding History

Athanor Capital’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,113
Closed -$161K – 434
2021
Q1 		$161K Sell
21,113
-72,865
-78% -$520K ﹤0.01% 761
2020
Q4 		$486K Hold
93,978
– – 0.01% 474
2020
Q3 		$459K Buy
93,978
+6,578
+8% +$47.2K 0.02% 352
2020
Q2 		$588K Buy
87,400
+14,892
+21% +$108K 0.03% 276
2020
Q1 		$501K Sell
72,508
-19,864
-22% -$155K 0.03% 130
2019
Q4 		$787K Sell
92,372
-16,168
-15% -$108K 0.04% 194
2019
Q3 		$537K Buy
108,540
+66,440
+158% +$356K 0.03% 148
2019
Q2 		$234K Buy
+42,100
New +$215K 0.03% 122

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Athanor Capital's ACIU Position: Q2 2021 in Review

Athanor Capital sold out of AC Immune (ACIU) in Q2 2021, closing a stake of 21,113 shares — an estimated $161K sold.

Athanor Capital first reported a position in ACIU in Q2 2019 and held it in 8 quarters. The position peaked at $787K in Q4 2019. 57 funds tracked by Wall St. Rank hold ACIU as of Q2 2021.

  • Athanor Capital reported no remaining AC Immune position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 21,113 AC Immune shares in Q2 2021, an estimated $161K.
  • Athanor Capital first reported a position in AC Immune in Q2 2019 and held it in 8 quarters.
  • Athanor Capital's AC Immune position peaked at $787K in Q4 2019.
  • 57 funds tracked by Wall St. Rank held AC Immune as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.